Insider Trading activities of Unigene Laboratories Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Unigene Laboratories Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Unigene Laboratories Inc since year 2005. Table 2 shows the detailed insider transactions of Unigene Laboratories Inc since 2005. The reporting company's ticker symbol is UGNE. The reporting company's CIK number is 352747.
The total value of stock buying since 2005 is $523,277.
The total value of stock sales since 2005 is $832,653.
The total value of stock option exercises since 2005 is $745,144.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Unigene Laboratories Inc (UGNE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2011-12 163,900 $97,376 0 $0 0 $0
2011-06 0 $0 0 $0 85,000 $29,475
2010-12 266,100 $193,441 0 $0 150,000 $70,500
2010-09 20,800 $14,709 0 $0 0 $0
2010-08 286,550 $187,394 0 $0 0 $0
2010-06 21,200 $16,642 0 $0 0 $0
2009-12 0 $0 42,250 $39,291 0 $0
2009-11 0 $0 100,500 $110,765 129,195 $86,786
2009-10 0 $0 0 $0 104,750 $55,017
2009-08 0 $0 0 $0 161,000 $75,831
2008-11 11,500 $6,815 0 $0 10,000 $4,400
2007-05 600 $1,440 0 $0 0 $0
2006-06 1,000 $3,460 0 $0 0 $0
2006-03 500 $2,000 50,000 $187,400 50,000 $15,250
2006-02 0 $0 0 $0 100,000 $39,500
2005-12 0 $0 120,000 $495,197 180,000 $368,385

Table 2. Detailed insider stock purchases, sales, and option exercises of Unigene Laboratories Inc insiders (UGNE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-12-21 Thomas Jenene D. (VP of Investor Relations) Buy 2,000 .52 1,050
2011-12-21 Tavakkol Roxanne (VP, Global Regulatory Affairs) Buy 1,500 .64 952
2011-12-21 Tune Joel A. (Director) Buy 15,000 .56 8,475
2011-12-21 Palmer Ashleigh (President & CEO) Buy 10,000 .53 5,280
2011-12-21 Mayes, Gregory T. (VP, Corp Development and GC) Buy 2,000 .52 1,050
2011-12-21 Odlaug Theron Edwin (Director) Buy 10,000 .53 5,300
2011-12-21 Advanced Life Sciences Holdings, Inc. (Director) Buy 10,000 .53 5,300
2011-12-21 Mehta Nozer (VP, Biological R&D) Buy 1,400 .54 749
2011-12-21 Shields Paul (Vice Pres. Mfg. Operations) Buy 2,000 .52 1,050
2011-12-21 Sabatino Thomas J Jr (Director) Buy 100,000 .63 62,900
2011-12-21 Zvi Eiref (Director) Buy 10,000 .53 5,270
2011-06-20 Bloom Allen (Director) Option Ex 10,000 .66 6,600
2011-06-14 Mehta Nozer (Vice Pres. Biological R&D) Option Ex 75,000 .30 22,875
2010-12-22 Levy Richard N (Director) Buy 50,000 .74 37,000
2010-12-21 Levy Richard N (Director) Buy 50,000 .75 37,500
2010-12-21 Zvi Eiref (Director) Buy 5,000 .72 3,600
2010-12-20 Levy Richard N (Director) Buy 50,000 .75 37,500
2010-12-20 Zvi Eiref (Director) Buy 10,000 .73 7,300
2010-12-17 Levy Richard N (Director) Buy 26,100 .72 18,792
2010-12-17 Bloom Allen (Director) Option Ex 150,000 .47 70,500
2010-12-15 Levy Richard N (Director) Buy 75,000 .69 51,749
2010-09-21 Steinhauer William Jacob (Vice President of Finance) Buy 5,000 .69 3,449
2010-09-20 Palmer Ashleigh (President & CEO) Buy 8,800 .70 6,160
2010-09-03 Levy Richard N (Director) Buy 5,000 .72 3,600
2010-09-03 Slusser Peter (Director) Buy 2,000 .75 1,500
2010-08-31 Levy Richard N (Director) Buy 50,000 .70 35,000
2010-08-30 Levy Richard N (Director) Buy 18,917 .68 12,863
2010-08-27 Levy Richard N (Director) Buy 176,633 .65 114,811
2010-08-17 Zvi Eiref (Director) Buy 17,000 .60 10,200
2010-08-16 Zvi Eiref (Director) Buy 4,000 .63 2,520
2010-08-12 Palmer Ashleigh (President & CEO) Buy 20,000 .60 12,000
2010-06-18 Palmer Ashleigh (President & CEO) Buy 21,200 .78 16,642
2009-12-02 Shields Paul (Vice Pres. Mfg. Operations) Sale 14,762 .93 13,728
2009-12-01 Shields Paul (Vice Pres. Mfg. Operations) Sale 27,488 .93 25,563
2009-11-30 Shields Paul (Vice Pres. Mfg. Operations) Sale 25,500 .93 23,715
2009-11-25 Shields Paul (Vice Pres. Mfg. Operations) Option Ex 14,195 1.01 14,336
2009-11-04 Gilligan James P (Vice Pres. of Product Devel.) Sale 65,000 1.15 74,750
2009-11-03 Gilligan James P (Vice Pres. of Product Devel.) Sale 10,000 1.23 12,300
2009-11-03 Gilligan James P (Vice Pres. of Product Devel.) Option Ex 115,000 .63 72,450
2009-10-28 Steinhauer William Jacob (Vice President of Finance) Option Ex 17,000 .63 10,710
2009-10-27 Shields Paul (Vice Pres. Mfg. Operations) Option Ex 67,750 .47 31,707
2009-10-19 Levy Jay (Treasurer) Option Ex 20,000 .63 12,600
2009-08-19 August Joseph T (Director) Option Ex 161,000 .47 75,831
2008-11-18 Bloom Allen (Director) Option Ex 10,000 .44 4,400
2008-11-14 Hendrickson Robert F (Director) Buy 10,000 .59 5,900
2008-11-13 Slusser Peter (Director) Buy 1,500 .61 915
2007-05-23 Gilligan James P (Vice Pres. of Product Devel.) Buy 600 2.40 1,440
2006-06-12 Miller Marvin (Director) Buy 1,000 3.46 3,460
2006-03-22 Shields Paul (Vice Pres. Mfg. Operations) Sale 40,000 3.71 148,400
2006-03-22 Shields Paul (Vice Pres. Mfg. Operations) Option Ex 40,000 .30 12,200
2006-03-21 Shields Paul (Vice Pres. Mfg. Operations) Sale 10,000 3.90 39,000
2006-03-21 Shields Paul (Vice Pres. Mfg. Operations) Option Ex 10,000 .30 3,050
2006-03-21 Slusser Peter (Director) Buy 500 4.00 2,000
2006-02-17 Mehta Nozer (Vice Pres. Biological R&D) Option Ex 100,000 .40 39,500
2005-12-21 Gilligan James P (Vice Pres. of Produc) Sale 20,000 4.50 90,000
2005-12-21 Gilligan James P (Vice Pres. of Produc) Option Ex 20,000 1.97 39,380
2005-12-08 Gilligan James P (Vice Pres. of Produc) Sale 36,500 4.12 150,562
2005-12-08 Gilligan James P (Vice Pres. of Produc) Option Ex 96,500 1.56 150,443
2005-12-07 Gilligan James P (Vice Pres. of Produc) Sale 63,500 4.01 254,635
2005-12-07 Gilligan James P (Vice Pres. of Produc) Option Ex 63,500 2.81 178,562

Insider trading activities including stock purchases, stock sales, and option exercises of UGNE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Unigene Laboratories Inc (symbol UGNE, CIK number 352747) see the Securities and Exchange Commission (SEC) website.